Drug design from the cryptic inhibitor envelope
The conformational dynamics of a compound has a large effect on ligand/receptor binding. Here, the authors employ NMR spectroscopy to study ligand binding to the enzyme LpxC, discovering an inhibitor envelope that was not identifiable by crystallography and subsequently developing a highly potent in...
Guardado en:
Autores principales: | Chul-Jin Lee, Xiaofei Liang, Qinglin Wu, Javaria Najeeb, Jinshi Zhao, Ramesh Gopalaswamy, Marie Titecat, Florent Sebbane, Nadine Lemaitre, Eric J. Toone, Pei Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7d0d77eb2224e92ad9e99b31e87c12f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC
por: Nadine Lemaître, et al.
Publicado: (2017) -
The Lipid A 1-Phosphatase, LpxE, Functionally Connects Multiple Layers of Bacterial Envelope Biogenesis
por: Jinshi Zhao, et al.
Publicado: (2019) -
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
por: Ashley N. Matthew, et al.
Publicado: (2020) -
Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.
por: Elodie Teissier, et al.
Publicado: (2011) -
Cryptic contamination and phylogenetic nonsense.
por: Anna Linderholm, et al.
Publicado: (2008)